The study suggests that TIGD1 accelerates the transition of cancer cells from the G1 to the S phase by triggering various colon cancer signaling pathways, such as Wnt/B-catenin, E-cadherin, N-cadherin, Bcl-2, BAX, CDK6, and cyclin D1. Here, TIGD1 is linked to cancer.